The China Women’s Health market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
In 2019, China’s female population reached 684 million, accounting for 48.91% of the country’s total population. The female population is large in scale and continues to grow, which has brought a large space for the female health service market. 3 out of every 10 women in China have dysmenorrhea; 46% of women have irregular menstrual periods. And showing a younger trend, more than 30% of women have abnormal flow problems during menstruation.
The increasing geriatric population, a rise in the adoption of unhealthy lifestyle habits, and the introduction of novel medicines for women are some of the factors that drive market growth. Furthermore, favorable policies initiated by the government to improve women’s health and raise awareness are likely to drive market growth during the forecast period. Women are at a higher risk of diseases such as osteoporosis, osteoarthritis, anemia, menstrual health-related disorders, depression, and obesity. Hence, increasing incidences of these conditions are likely to boost market growth in the coming years.